EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The LncRNA–Tumor Immune Microenvironment Nexus: Integrative Insights for Cancer Immunotherapy

Juwon Lee, Revathy Nadhan, Yong Sang Song, Danny N Dhanasekaran

Genomics, Proteomics & Bioinformatics · 17.08.2026

DOI: 10.1093/gpbjnl/qzag084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genomics, Proteomics & Bioinformatics, online erschienen am 17.08.2026. Verfasst von Juwon Lee und 3 weiteren Autor:innen. Beteiligte Einrichtung: Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Long non-coding RNAs (lncRNAs) have emerged as pivotal regulators of tumor–immune interactions, bridging epigenetic, transcriptional, and post-transcriptional control of immune signaling networks. Recent multi-omics analyses reveal that lncRNAs shape the tumor immune microenvironment (TIME) by influencing immune-cell differentiation, activation, and exhaustion, as well as cytokine, chemokine, and immune-checkpoint pathways. Acting through molecular scaffolding, chromatin remodeling, and competing endogenous RNA (ceRNA) mechanisms, lncRNAs orchestrate the recruitment and functional polarization of lymphoid and myeloid populations, thereby dictating the balance between antitumor immunity and immune suppression. Integrative evidence further links specific lncRNA signatures to PD-1/PD-L1 checkpoint regulation, metabolic reprogramming, and therapeutic resistance. Here, we synthesize current discoveries defining the lncRNA–TIME nexus and highlight advances in high-throughput sequencing, single-cell transcriptomics, and computational modeling that enable the mapping of these complex networks. We discuss the translational promise of targeting lncRNAs as biomarkers and therapeutic nodes to enhance immunotherapy efficacy. Collectively, these integrative insights position lncRNAs as critical molecular interfaces connecting tumor genomics with immune regulation and open new avenues for precision immuno-oncology.

Schlagwörter

Stichwörter der Autor:innen

CancerImmunotherapyLncRNATargeted therapyTumor immune microenvironment

Autor:innen und Institutionen

  • Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
  • Department of Obstetrics and Gynecology, Myongji Hospital, Gyeonggi-do 10475, Republic of Korea.
  • Department of Cell Biology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
  • Department of Pathology, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.

Zitieren

APA

Lee, J., Nadhan, R., Song, Y. S., & Dhanasekaran, D. N. (2026). The LncRNA–Tumor Immune Microenvironment Nexus: Integrative Insights for Cancer Immunotherapy. Genomics, Proteomics & Bioinformatics. https://doi.org/10.1093/gpbjnl/qzag084

Vancouver

Lee J, Nadhan R, Song YS, Dhanasekaran DN. The LncRNA–Tumor Immune Microenvironment Nexus: Integrative Insights for Cancer Immunotherapy. Genomics, Proteomics & Bioinformatics. 2026. doi:10.1093/gpbjnl/qzag084

BibTeX
@article{Lee2026,
  author = {Lee, Juwon and Nadhan, Revathy and Song, Yong Sang and Dhanasekaran, Danny N},
  title = {The LncRNA–Tumor Immune Microenvironment Nexus: Integrative Insights for Cancer Immunotherapy},
  journal = {Genomics, Proteomics & Bioinformatics},
  year = {2026},
  doi = {10.1093/gpbjnl/qzag084}
}
Kostenlos starten →